Henry Charles Kitchener

机构：University of Manchester, Cancer Research UK Manchester Institute · ORCID：0000-0001-5791-7838

发表论文 376 篇 · 总被引 29664 次 · h-index 77

代表论文

• Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy (2020 · Journal of Clinical Oncology · 被引 872)
• Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial (2018 · The Lancet Oncology · 被引 643)
• Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial (2019 · The Lancet Oncology · 被引 465)
• Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials (2018 · The Lancet Oncology · 被引 318)
• Primary cervical screening with high risk human papillomavirus testing: observational study (2019 · BMJ · 被引 179)
• The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk (2018 · International Journal of Cancer · 被引 128)